Cytokine Inhibitors and Graft‐versus‐Host Disease
- 17 December 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 770 (1) , 227-236
- https://doi.org/10.1111/j.1749-6632.1995.tb31058.x
Abstract
Click on the article title to read more.Keywords
This publication has 29 references indexed in Scilit:
- Cytokine gene expression in mice undergoing chronic graft-versus-host diseaseMolecular Immunology, 1993
- Differential cytokine expression in acute and chronic murine graft‐versus‐host‐diseaseEuropean Journal of Immunology, 1993
- Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantationThe Lancet, 1993
- Effects of in vivo administration of interferon (IFN)-γ, anti-IFN-γ, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host diseaseClinical Immunology and Immunopathology, 1992
- SERUM LEVELS AND RECEPTOR EXPRESSION OF TUMOR NECROSIS FACTOR-α FOLLOWING HUMAN ALLOGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANTATIONTransplantation, 1992
- Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.The Journal of Experimental Medicine, 1992
- Enhancement of Growth of Virulent Strains of Escherichia coli by Interleukin-1Science, 1991
- ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATIONTransplantation, 1990
- In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.The Journal of Experimental Medicine, 1990
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987